Frozmetics Healthcare

Innovating to improve skin health

Frozmetics is a research and development company specializing in the design of innovative skincare solutions. Through a unique patented technology, we are developing a new generation of healthcare products that combine the therapeutic benefits of cold therapy with the effectiveness of carefully selected natural active ingredients.
Our formulations are 100% natural, preservative-free, and designed to be frozen by the user. Unlike conventional products, they remain liquid at low temperatures, allowing direct application to the skin as a cold cream or serum.

A patented technology serving patients

Our innovation is based on a novel approach: transforming cold into a true therapeutic tool.
Thanks to our patented technology:

• • Active ingredients, including the most fragile ones, are optimally stabilized;
• • The product delivers a genuine, immediate, and pleasant cooling sensation;
• • The benefits of cold therapy are combined with those of high-performance natural ingredients;
• • The formulations provide enhanced safety through the absence of preservatives.

This unique combination enables the development of safer and more effective products that meet the requirements of the medical device category and pave the way for scientifically validated health claims.

First application: Managing radiation dermatitis

Frozmetics’ first therapeutic indication focuses on radiation dermatitis, a skin condition similar to a burn caused by radiotherapy treatments.
Each year, nearly 10 million patients worldwide undergo radiotherapy, and almost all of them develop some form of radiation dermatitis.

The consequences of radiation dermatitis

This skin inflammation can:

• Persist for several months;
• Cause significant pain and discomfort;
• Substantially impair patients’ quality of life;
• In the most severe cases, lead to interruptions in cancer treatment.

To address this still largely unmet medical need, Frozmetics is developing an innovative solution aimed at improving patient comfort and care.

A high-potential technology platform

Beyond radiation dermatitis, our technology has the potential to be adapted to a wide range of dermatological applications.

Future indications may include:

Skin disorders

The concept can be tailored to various skin conditions requiring soothing, restorative, or anti-inflammatory action.

Aesthetic medicine

The technology also shows strong potential for managing side effects associated with aesthetic procedures such as:

• Laser treatments;
• Chemical peels;
• Non-invasive dermatological procedures.

The combination of therapeutic cooling and targeted active ingredients may help reduce discomfort, redness, and inflammatory reactions following treatment.

An ambitious development roadmap

The clinical development of our first solution follows a structured timeline:

• 2026: Proof-of-concept study;
• Late 2026: Initial clinical results;
• 2027: CE marking approval;
• 2028: Commercial launch through an industrial partner.

This strategy is designed to rapidly bring a breakthrough innovation to patients while addressing a significant unmet medical need.

Transforming cold into therapeutic innovation

At Frozmetics, we believe that cold therapy remains an underutilized therapeutic resource.
Our mission is to develop natural, effective, and scientifically validated solutions that improve patients’ quality of life and open new possibilities in the treatment of skin conditions.

Frozmetics transforms cold into a therapeutic tool for the benefit of patients.